[Short and long-term therapeutic efficacy of drug-eluting stents (Firebird) for the treatment of coronary artery disease].
To evaluate the short and long-term therapeutic efficacy of drug-eluting stents (Firebird) for the treatment of coronary artery disease. From Nov. 2003 to Jan. 2005, 501 Firebird stents were implanted in 410 patients with 460 lesions. All patients were administered with aspirin and clopidogrel before and after the procedures. Follow-up was made by telephone or interview, 102 out of 410 patients were followed up by angiography. The procedure success rate was 99.5%. Stent thrombosis occurred in one patient during the procedure and one sudden death developed 10 hours after the procedure in hospital. The major adverse cardiac event (MACE, including death, acute myocardial infarction and target lesion revascularization) rate during hospitalization was 0.2% (1/410). The MACE rate was 4.3% (16/376) and the stent thrombosis rate was 1.1% (4/376) during clinical follow-up of 376 patients (12.8 +/- 3.2 months). The angiographic restenosis rate in 102 patients with 122 lesions was 9.8% (12/122). Firebird drug-eluting stent could be used safely and effectively in patient with coronary heart disease.